Novel therapy for obesity: The Munich-based medtech company Sedivention aims to facilitate the treatment of obesity with a new type of catheter – an approach that the company has already demonstrated at this year’s Munich Business Plan Competition How the startup, founded in 2021 by Ute Nollert, Stéphane Delaloye, and André Burch, intends to combat the 'hunger nerve' and why this treatment method can become a real game changer for those affected, the founders report in an interview. (Photo: Sedivention)